Fennec Pharmaceuticals Inc
F:RV41
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fennec Pharmaceuticals Inc
F:RV41
|
US |
|
M
|
Macy's Inc
DUS:FDO
|
US |
|
A
|
Asia Plus Group Holdings PCL
SET:ASP
|
TH |
|
Swedbank AB
F:FRY
|
SE |
|
N
|
Nebius Group NV
XMUN:YDX
|
NL |
|
F
|
Factset Research Systems Inc
DUS:FA1
|
US |
|
C
|
CNH Industrial NV
XMUN:37C
|
UK |
|
Coty Inc
PAR:COTY
|
US |
|
J
|
Juventus FC SpA
XMUN:JUVE
|
IT |
Wall St Price Targets
RV41 Price Targets Summary
Fennec Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RV41 is 10.72 EUR with a low forecast of 8.81 EUR and a high forecast of 12.68 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV41's stock price target?
Price Target
10.72
EUR
According to Wall Street analysts, the average 1-year price target for RV41 is 10.72 EUR with a low forecast of 8.81 EUR and a high forecast of 12.68 EUR.
What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Revenue over the next 8 years is 24%.
What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%
The compound annual growth rate for Gross Profit over the next 8 years is 24%.
